RCS - Down MicroCap InvTst - Results analysis from Kepler Trust Intelligence

Downing Strategic Micro-Cap Investment TrustAnnouncement

11/05/2021 09:25

RNS Number : 2127Y
  
Downing Strategic Micro-Cap IT PLC
  
11 May 2021
  
 

Downing Strategic Micro Cap (DSM) 
11/05/2021
 
Results analysis from Kepler Trust Intelligence
Downing Strategic Micro-Cap (DSM) has published its annual report for the year ending 28/02/2021. The £46m trust aims to benefit from market inefficiencies amongst the UK's smallest listed companies. The management team employ a highly concentrated 'value' investment strategy based on fundamental analysis. They aim to buy strategic stakes (between 3% and 25%) in companies at prices that suggest a good 'margin of safety', but that are mispriced thanks to a problem or issue (real or misunderstood), but which is surmountable. Where necessary, the team engage with the senior management or board in order to effect change.
Since the start of the last financial year (largely 'pre-covid', 29/02/2020) the NAV return has been 26%. Much of these gains have come during 2021, which has seen a revival in interest for 'value' as an investment style as well as the UK equity market. Since the start of 2021, NAV performance has been respectable compared to the Numis Smaller Companies Index, with DSM's NAV total returns of 15.9% comparing to 16.3% for the index. The weighted average of the AIC UK Smaller Companies sector over the same period is 19.6%, likely boosted by the large Aberforth Smaller Companies Trust which has seen a strong bounce in returns also reflecting value coming back into favour.
Kepler view
A significant divestment from DSM's largest holding, Real Good Food (RGD, of which more below) is a key development for the trust, and the repayment of around half of the outstanding loan notes at a premium to par contributing to a c. 1% uplift in NAV. We believe this transaction proves the value of the Downing team's private equity style approach to investing in undervalued opportunities, and identifying (and, via their activism, helping to bring about) catalysts for value creation. As a result of the RGD transaction, cash will stand at c. 20% of NAV, giving the team plenty of flexibility to pursue new investments.
 
Of note in this regard, is the trust's first unlisted investment which we understand completed on 30 April 2021 in Tactus Holdings. DSM has invested around half of its purchase through a debt instrument and half through equity, representing a structured approach. Tactus Holdings is a strongly performing IT supplier, which has (amongst other contracts) recently signed a significant deal with the Department for Education. The fundraising that DSM participated in was made to enable the purchase of PC gaming specialists CCL Computers.
 
The managers are fundamentals based, which means taking an absolute view as to how future cash flows and assets can be valued, and looking for a catalyst for value to be realised. In the current market, with multiple indications flashing that markets are potentially getting ahead of themselves, this should provide some reassurance for investors. Part of the manager's raison d'etre is that they aim to invest in companies whose prospects are fundamentally undervalued by the market. Being undervalued already, means that one can hope that this gives an element of downside protection in market falls. The experience of Q1 2020 supports this thesis although as with any performance metric, there are no guarantees that this will occur in the future.
 
The progress at RGD (the sale of the Brighter Foods investment, with a c. £20m gain made over three years) marks a further step forward on what Downing hope will be a profitable investment journey overall. The team invested in RGD's equity, but a majority of the capital through loan notes and a convertible. This structured approach has limited DSM's exposure to the downside, and on capital realised has so far generated an attractive IRR of just under Downing's target annualized return for investments of 15%. With the remaining stake (loan, convertible and equity) accounting for just under 10% of NAV, it remains an important investment for shareholders. With the RGD board intent on realising as much value for the company's remaining Renshaw division and property assets, further value crystalisation appears to be more a question of "how much" and "how long", rather than "if?"
 
Click here to read the note in full
 
Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.
 
Important information
This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.
Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.
The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.
The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.
This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  
Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.
PLEASE SEE ALSO OUR TERMS AND CONDITIONS
Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.
Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.
 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NRAMZGMKRMVGMZG